A commercial-stage biotechnology company focused on therapies for acute pain management and chemotherapy-induced nausea and vomiting. Its portfolio includes non‑opioid post‑surgical pain treatment Zynrelef and antiemetic drugs such as Cinvanti, with revenue tied to hospital and oncology clinic adopt...
This page tracks all publicly disclosed congressional trades in Heron Therapeutics, Inc. (APPAD), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
No congressional trades found for this stock.